Singapore markets closed
Straits Times Index
3,307.90 -6.15 (-0.19%) S&P 500
5,308.13 +4.86 (+0.09%) Dow
39,806.77 -196.82 (-0.49%) Nasdaq
16,794.88 +108.91 (+0.65%) Bitcoin USD
71,267.29 +4,170.14 (+6.22%) CMC Crypto 200
1,538.26 +49.72 (+3.34%)
BMY Jan 2025 55.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 10:03AM EDT. Market open.
| Previous close | 0.6000 |
| Open | 0.6000 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 55.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.6000 - 0.6300 |
| Contract range | N/A |
| Volume | |
| Open interest | 18.29k |
Business WireBristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivolumab and hyaluronidase)
PRINCETON, N.J., May 21, 2024--Bristol Myers Squibb Announces Updated Action Date by the U.S. Food and Drug Administration for Subcutaneous Nivolumab (nivo and hyaluronidase)
Simply Wall St.Bristol-Myers Squibb Company (NYSE:BMY) is a favorite amongst institutional investors who own 79%
Key Insights Given the large stake in the stock by institutions, Bristol-Myers Squibb's stock price might be vulnerable...
ZacksThe Zacks Analyst Blog Highlights Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers
Novavax, Sanofi, Fulcrum Therapeutics, Moderna and Bristol Myers are included in this Analyst Blog.
© 2024 Yahoo. All rights reserved.